Home

Recent Articles from Benzinga

Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.

What the Options Market Tells Us About Coeur Miningbenzinga.com
Via Benzinga · December 15, 2025
How Is The Market Feeling About TE Connectivity PLC?benzinga.com
Via Benzinga · December 15, 2025
Peering Into Netflix Inc's Recent Short Interestbenzinga.com
Via Benzinga · December 15, 2025
Looking Into Unum Group's Recent Short Interestbenzinga.com
Via Benzinga · December 15, 2025
A Look Into APi Group Inc's Price Over Earningsbenzinga.com
Via Benzinga · December 15, 2025
From AI To Au: Why Investors Are Piling Into Gold ETFs Againbenzinga.com
Gold ETFs are back in focus as bullion nears record highs, tech valuation concerns grow and rate-cut bets rise.
Via Benzinga · December 15, 2025
A Look Into Natural Grocers Inc's Price Over Earningsbenzinga.com
Via Benzinga · December 15, 2025
What's Driving the Market Sentiment Around MP Materials Corp?benzinga.com
Via Benzinga · December 15, 2025
What's Driving the Market Sentiment Around Knightscope Inc?benzinga.com
Via Benzinga · December 15, 2025
What Does the Market Think About CRH PLC?benzinga.com
Via Benzinga · December 15, 2025
3 Great Retail Stocks For the Holiday Seasonbenzinga.com
The holiday season is here and retailers are expecting a trillion-dollar shopping season. Wall Street is watching value-driven and e-commerce retailers for investment opportunities.
Via Benzinga · December 15, 2025
Bitcoin, Ethereum Plummet 5%, But Traders Bet One Will Recover Until 2026benzinga.com
Bitcoin (CRYPTO: BTC) and Ethereum
Via Benzinga · December 15, 2025
They Want To Spend Their Emergency Fund On A 10-Year-Old's Dance Competition Trips. Dave Ramsey Says, 'You're Broke. That's So Screwed Up'benzinga.com
Via Benzinga · December 15, 2025
Phillips 66 To Invest Billions In Refining, NGL Growth Projects By 2026benzinga.com
Phillips 66 sets a $2.4 billion budget for 2026, with $1.3 billion allocated for growth initiatives, including NGL and refining projects.
Via Benzinga · December 15, 2025
JPMorgan Stock Hits All-Time High: What's Going On?benzinga.com
Shares of JPMorgan Chase (NASDAQ: JPM) are trending higher on Monday. Here's what investors need to know.
Via Benzinga · December 15, 2025
10 Industrials Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · December 15, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · December 15, 2025
12 Industrials Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · December 15, 2025
Death Cross Alert: Norwegian Cruise Stock Turns Bearish As Leadership Shiftsbenzinga.com
Norwegian Cruise (NCLH) stock flashes a Death Cross just as Leadership change adds uncertainty in turbulent market.
Via Benzinga · December 15, 2025
DOGE Bleeds Another 4% And The Worst May Be Yet To Comebenzinga.com
Dogecoin (CRYPTO: DOGE) is down over 4% on Monday, with the chart signaling downside risk toward the $0.08 area rather than
Via Benzinga · December 15, 2025
Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaborationbenzinga.com
Sanofi expands its partnership with Dren Bio in a deal featuring $100 million upfront and up to $1.7 billion tied to a next-generation autoimmune B-cell therapy.
Via Benzinga · December 15, 2025
Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impactbenzinga.com
BofA raised Johnson & Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through 2026.
Via Benzinga · December 15, 2025
Micron Stock Climbs As Wedbush Says Shares Are Headed To $300benzinga.com
Micron Technology Inc (NASDAQ:MU) shares climbed on Monday after Wedbush reiterated its bullish stance and lifted its price target.
Via Benzinga · December 15, 2025
Behind the Scenes of Carvana's Latest Options Trendsbenzinga.com
Via Benzinga · December 15, 2025
Merck & Co's Options: A Look at What the Big Money is Thinkingbenzinga.com
Via Benzinga · December 15, 2025
Is the Market Bullish or Bearish on BridgeBio Pharma Inc?benzinga.com
Via Benzinga · December 15, 2025
'To Whom Much Is Given, Much Is Expected,' Melinda French Gates Says, Urging Billionaires Backed By America's System To Give Away Far More Moneybenzinga.com
Via Benzinga · December 15, 2025
ServiceNow Faces Potential Microsoft Challenge To Its AI Orchestration Lead In 2026, Analyst Saysbenzinga.com
Keybanc lowers ServiceNow rating during slowing SaaS growth, rising AI pressures, and potential loss of AI orchestration leadership to Microsoft in 2026.
Via Benzinga · December 15, 2025
Lennar Q4 Preview: Buffett's Homebuilder Bet Beat Revenue In 8 Of Last 10 Quartersbenzinga.com
Lennar reports Q4 financial results Tuesday. The earnings could be closely watched by investors to see how the housing market is doing.
Via Benzinga · December 15, 2025
Bristol Myers Trades At Trough Valuation — Analyst Says Pipeline Upside Is Being Ignoredbenzinga.com
Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and improving risk-reward outlook.
Via Benzinga · December 15, 2025
Applied Digital Stock Is Tumbling Today: What's Going On?benzinga.com
Applied Digital Corp (NASDAQ:APLD) shares are trending on Monday amid a sharp decline. Here's a look at what you need to know.
Via Benzinga · December 15, 2025
Is Newmont Corp Gaining or Losing Market Support?benzinga.com
Via Benzinga · December 15, 2025
How Do Investors Really Feel About Lincoln National Corp?benzinga.com
Via Benzinga · December 15, 2025
A Look Into AppLovin Inc's Price Over Earningsbenzinga.com
Via Benzinga · December 15, 2025
Why iRobot Stock Could Pull A 'Zombie Squeeze' — The Walking Debtbenzinga.com
Retail traders with a very high risk tolerance might look for a "zombie squeeze" from iRobot.
Via Benzinga · December 15, 2025
10 Consumer Discretionary Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · December 15, 2025
10 Information Technology Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · December 15, 2025
Tesla Eyes Record Highs, Bitcoin Tumbles To $86,000: What's Moving Markets Monday?benzinga.com
Wall Street traded little changed Monday after last Friday’s tech-led sell-off failed to trigger meaningful dip-buying interest. By midday trading in New York, major indexes hovered near flat levels as investors stayed cautious ahead of a dense macro calendar this week.
Via Benzinga · December 15, 2025
Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analystbenzinga.com
Pfizer to provide full-year 2026 financial guidance on Tuesday. BofA analyst expects flat growth, reiterates Neutral rating.
Via Benzinga · December 15, 2025
Three Different Central Bank Actions To Shape The FX Weekbenzinga.com
Via Benzinga · December 15, 2025
Elon Musk Says He's Been Having 'AI Nightmares' Lately —'If I Could, I Would Certainly Slow Down AI And Robotics, But I Can't'benzinga.com
Via Benzinga · December 15, 2025
Crude Oil Falls Over 1%; US Homebuilder Sentiment Edges Higher In Decemberbenzinga.com
Via Benzinga · December 15, 2025
ABM Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga.com
Via Benzinga · December 15, 2025
Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goalbenzinga.com
Gilead said its two-drug bictegravir-lenacapavir tablet was non-inferior to Biktarvy in the Phase 3 ARTISTRY-2 HIV trial.
Via Benzinga · December 15, 2025
Why Is Immunome Stock Soaring Monday?benzinga.com
Immunome stock surges after positive results from Phase 3 trial for desmoid tumors, meeting all key endpoints.
Via Benzinga · December 15, 2025
Stablecoin Institutional Adoption Hits New Milestone As Visa Targets $310B Marketbenzinga.com
Visa Inc.
Via Benzinga · December 15, 2025
Why Alphabet ETFs Could Get A Lift From SpaceX's $800 Billion Valuation Jumpbenzinga.com
Alphabet's SpaceX stake may boost its earnings again, putting Alphabet-heavy ETFs in focus as private-market gains ripple into public ETF returns.
Via Benzinga · December 15, 2025
Patrick Mahomes Injury Puts Pressure On Amazon Stock: Will Viewers Pick 'Stranger Things' Over NFL?benzinga.com
The Patrick Mahomes injury and Kansas City Chiefs missing the NFL Playoffs in the 2025 season could be bad news for Amazon stock. Here's why.
Via Benzinga · December 15, 2025
12 Consumer Discretionary Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · December 15, 2025
12 Information Technology Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · December 15, 2025
What's Driving The Sell-Off In Luminar Technologies (LAZR) Stock?benzinga.com
Luminar shares are under heavy pressure Monday after the company announced that it initiated voluntary Chapter 11 proceedings.
Via Benzinga · December 15, 2025
Eli Lilly's Obesity Drug Dominance Still Underpriced By Market, Bank of America Saysbenzinga.com
Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.
Via Benzinga · December 15, 2025
Small Caps Outperform Mag Seven; Key Economic Data Ahead; Gold Buying On Dollar Debasement Fearsbenzinga.com
Small Caps Outperforming Please click here for an enlarged chart of small cap iShares Russell 2000 ETF
Via Benzinga · December 15, 2025
Apple iPhone Lead Times Are Stretching — Analyst Sees Strong Year-End Demandbenzinga.com
Apple's iPhone 17 delivery lead times are rising across the US, China, and Europe, signaling resilient demand and supporting expectations for strong iPhone revenue growth into early 2026.
Via Benzinga · December 15, 2025
'I'm 53 Years Old, Have Absolutely Nothing For Retirement, I'm $50K in Debt And I Want a Divorce' — Dave Ramsey Tells Truck Driver Stop Playing Victimbenzinga.com
Via Benzinga · December 15, 2025
Why Is Radiopharm Theranostics Stock Rallying Over 140%?benzinga.com
Radiopharm Theranostics shares rise after interim Phase 2b data showed 92% MRI concordance for RAD 101 imaging in brain metastases.
Via Benzinga · December 15, 2025
CrowdStrike Says AI Prompts Are The New Malwarebenzinga.com
CrowdStrike introduces Falcon AI Detection and Response, expanding its platform to secure the AI prompt and agent interaction layer.
Via Benzinga · December 15, 2025
AI Tokens Vs. AI Stocks: Promises Vs. Profitsbenzinga.com
Artificial intelligence dominates market conversations, spawning two competing investment narratives. One rides on blockchain promises and decentralized computing dreams. The other ships actual chips, generates billions in profit, and pays real dividends. As we head toward 2026, the gap between AI cryptocurrency tokens and traditional AI stocks isn’t just wide.
Via Benzinga · December 15, 2025
Palvella: 73% Improved In Phase 2 Study Of Skin Condition Treatmentbenzinga.com
Palvella Therapeutics reports Phase 2 data showing 73% improvement with QTORIN rapamycin gel in cutaneous venous malformations.
Via Benzinga · December 15, 2025
Here's How Much You Would Have Made Owning Tyler Technologies Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · December 15, 2025
If We Don't Take Them, the Chinese Are Going to Take Them" — Kevin O'Leary Says It's 'Insane' to Deny Foreign Students U.S. College Accessbenzinga.com
Via Benzinga · December 15, 2025
Investors Double Down On 'Run It Hot' Trade: Is Your Portfolio At Risk?benzinga.com
A growth-first mindset is pushing markets higher. This breakdown explains the "Run It Hot" trade and where investors may be mispricing risk.
Via Benzinga · December 15, 2025
This AMC Networks Analyst Is No Longer Bullish Amid Netflix-Paramount Battle For Warner Bros Discoverybenzinga.com
AMCX shares rally as Netflix, Paramount, and Warner Bros Discovery compete for acquisition. Seaport Research downgrades rating due to declining trends.
Via Benzinga · December 15, 2025
Canopy Growth To Acquire MTL Cannabisbenzinga.com
Canopy Growth Corp. (NASDAQ: CGC) to acquire MTL Cannabis Corp. (OTCQX: MTLNF) for approx. 125 million CAD in cash and stock.
Via Benzinga · December 15, 2025
Carnival Q4 Preview: Choppy Results; Analyst Expects 2026 To Be Catalyst-Drivenbenzinga.com
Carnival Corp (CCL) to report Q2 results on 12/18. Analyst maintains Buy rating, expects in-line results. Stock may benefit from new destination and diversification.
Via Benzinga · December 15, 2025
Trane Selloff Creates 'Rare Entry Point,' Analyst Saysbenzinga.com
Analyst upgrades Trane Technologies to Overweight and praises its strong CHVAC portfolio and potential in the data center market. Price target: $500.
Via Benzinga · December 15, 2025
Here's How Much You Would Have Made Owning Encompass Health Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · December 15, 2025
Tesla Owner Regrets Thinking His EV Was An 'Investment'—Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Monthbenzinga.com
Via Benzinga · December 15, 2025
Poor People 'Pay The Price For Being Wrong' — Palantir CEO Alex Karp Blasts Leaders Getting Huge Bonuses After 'Stupid Decisions' And Government Helpbenzinga.com
Via Benzinga · December 15, 2025
Here's How Much $100 Invested In Casey's General Stores 5 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · December 15, 2025
What's Going On With BitMine (BMNR) Stock Today?benzinga.com
Shares of BitMine Immersion Technologies, Inc. (NASDAQ:BMNR) are trading lower Monday.
Via Benzinga · December 15, 2025
Elon Musk Says He Could 'Probably' Extend Human Lifespan, 'But I Don't Want To' Because People Must Die For Society To Progressbenzinga.com
Via Benzinga · December 15, 2025
Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?benzinga.com
Greenwich LifeSciences stock rose after Phase 3 data showed GLSI-100 cut breast cancer recurrence rates by about 80% in new patients.
Via Benzinga · December 15, 2025
Crypto Can No Longer Be Ignored Or Dismissed, 5%–10% Portfolio Allocation Is Warranted, Hashdex Saysbenzinga.com
Hashdex Asset Management recommends investors allocate 5%-10% to crypto as it becomes an essential part of portfolios due to macro pressures and growing institutional acceptance. Tokenization, AI, and stablecoins contribute to the growth of digital assets in the next 5 years.
Via Benzinga · December 15, 2025
Family Calls Him Selfish After He Traded For 82-Year-Old Grandma's Lottery Tickets In White Elephant Game And Won $25K But Kept It Allbenzinga.com
Via Benzinga · December 15, 2025